Artemisinin Combination Therapy
Showing 1 - 25 of >10,000
Malaria Trial in Kasese (Artemether/lumefantrine, Ivermectin)
Recruiting
- Malaria
-
Kasese, UgandaST. Paul's Health Center
Oct 31, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Malaria Trial in Mae Sot (dihydroartemisinin-piperaquine, Artesunate-mefloquine, arthemeter-lumefantrin)
Completed
- Malaria
- dihydroartemisinin-piperaquine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Mar 24, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Malaria, Febrile Illness Trial in Lagos (Testing incentive, Conditional artemisinin combination therapy subsidy)
Recruiting
- Malaria
- Febrile Illness
- Testing incentive
- Conditional artemisinin combination therapy subsidy
-
Lagos, NigeriaClinton Health Access Initiative
Feb 4, 2022
Malaria Trial in Goma (ACT, DLA1, DLA2)
Withdrawn
- Malaria
- ACT
- +2 more
-
Goma, N Kivu, Congo, The Democratic Republic of theRwanguba Reference Hospital
Oct 6, 2021
Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)
Active, not recruiting
- Plasmodium Falciparum
- RTS,S/AS01E
- Abhayrab rabies vaccine
-
Kisumu, Kisumu County, KenyaKombewa Clinical Research Center
Oct 7, 2021
Acceptability and Costs ofMultiple First-lines Artemisinin-based
Completed
- Malaria
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
Mar 24, 2022
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Malaria Trial (5-aminolevulinic acid HCl (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based
Withdrawn
- Malaria
- 5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD
- +5 more
- (no location specified)
Feb 28, 2020
Systemic Sclerosis Trial in Palermo (combination ultrasound therapy and manual therapy, manual therapy)
Completed
- Systemic Sclerosis
- combination ultrasound therapy and manual therapy
- manual therapy
-
Palermo, ItalyFunctional Recovery and Rehabilitation Unit of the A.O.U.P. Paol
Jun 18, 2023
Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)
Recruiting
- Androgenetic Alopecia
- Minoxidil 5% Topical Solution
- microneedling
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangungkusumo Hospital
Aug 3, 2023
Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Trial in Duarte (procedure, drug, other)
Not yet recruiting
- Advanced Prostate Carcinoma
- +4 more
- Bright White Light Therapy
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 8, 2023
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Uncomplicated Falciparum Malaria Trial in Ndola (Artemether-lumefantrine, Dihydroartemisinin-piperaquine)
Active, not recruiting
- Uncomplicated Falciparum Malaria
-
Ndola, Copperbelt, ZambiaTropical Diseases Research Centre
Aug 7, 2020
Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)
Recruiting
- Non-healing Wound
- Non-Healing Ulcer of Skin
- Omeza Products Used in Combination
-
Santa Fe, New MexicoChristus St. Vincent
Jun 19, 2023
TNFi as Monotherapy or Combination Therapy With MTX and Compare
Completed
- Rheumatoid Arthritis
- patterns of use of combination therapy and monotherapy
-
New York, New YorkPfizer
Oct 7, 2022
Back Pain Trial in Islamabad (muscle energy technique, Muscel energy technique along with interferential therapy)
Completed
- Back Pain
- muscle energy technique
- Muscel energy technique along with interferential therapy
-
Islamabad, Federal, PakistanThe Neurocouncil Clinic
Oct 18, 2023
Helicobacter Pylori Infection Trial (Lacidophilin tablets in combination with vonorazan dual therapy, Placebo in combination
Not yet recruiting
- Helicobacter Pylori Infection
- Lacidophilin tablets in combination with vonorazan dual therapy
- Placebo in combination with vonorazan dual therapy
- (no location specified)
Feb 18, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Available
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Aug 31, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Migraine Trial in Dhaka (Topiramate 25Mg Tab, Amitriptyline 25 Mg Oral Tablet, topiramate 25mg plus amitriptyline 25mg)
Enrolling by invitation
- Migraine
- Topiramate 25Mg Tab
- +2 more
-
Dhaka, BangladeshDhaka Medical College
Feb 26, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023